Introducing Atlas®: Multi-organ Phenotyping in Metabolic Diseases & COVID-19

Date: 16 November 2020

Time: 4:30pm GMT | 11:30am ET

Atlas® is a metabolic imaging suite redefining multi-organ assessment for clinical trials in diabetes and metabolic disease. It provides quantitative metrics of health and function across multiple organs from a single 30-minute, non-contrast MR scan. The utility of Atlas will be presented in a series of webinars throughout TLMdX 2020.

Key Topics
- Introducing the challenges of multi-organ involvement in chronic diseases
- Challenges of multi-organ assessment in clinical trials
- Introducing Atlas®
- Precision imaging examples
- Future of imaging for multi-organ assessment in clinical trials